Clinuvel Pharmaceuticals L T D

USPTO Trademark & Patent Filings

Clinuvel Pharmaceuticals L T D

Trademark applications and grants for Clinuvel Pharmaceuticals L T D. Clinuvel Pharmaceuticals L T D has 4 trademark applications. The latest application filed is for "SCENESSE"

Company Profile
    Company Aliases
  • Clinuvel Pharmaceuticals Limited
  • CLINUVEL PHARMACEUTICALS LTD - Melbourne, Victoria AU
  • Clinuvel Pharmaceuticals Limited - Melbourne AU
  • Clinuvel Pharmaceuticals Limited - Melbourne VIC AU

Trademarks Patents
Patent Applications
Patent ApplicationDate
ALPHA-MSH ANALOGUES USED IN THE TREATMENT OF XERODERMA PIGMENTOSUM
20200246436 - Kind Code
2020-08-06
METHODS OF INDUCING MELANOGENESIS IN A SUBJECT
20180360919 - 16/113580 KLEINIG; Michael John ;   et al.
2018-12-20
THERAPY FOR VITILIGO
20180008676 - 15/714627 Wolgen; Philippe
2018-01-11
METHODS OF INDUCING MELANOGENESIS IN A SUBJECT
20160235819 - 15/135241 KLEINIG; Michael John ;   et al.
2016-08-18
METHOD FOR REDUCING INCIDENCE OR RATE OF DEVELOPMENT OF SKIN CANCERS AND RELATED CONDITIONS
20130344153 - 14/016828 Wolgen; Philippe
2013-12-26
Patent Grants & Applications
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed